|
시장보고서
상품코드
1908608
대규모 및 소규모 바이오프로세싱 시장 규모, 점유율, 동향 분석 보고서 : 규모별, 워크플로우별, 제품별, 용도별, 사용 유형별, 모드별, 지역별, 부문별 예측(2026-2033년)Large And Small-scale Bioprocessing Market Size, Share & Trends Analysis Report By Scale, By Workflow (Downstream, Upstream), By Product, By Application, By Use Type, By Mode (In-house, Outsourced), By Region, And Segment Forecasts, 2026 - 2033 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
대규모 및 소규모 바이오프로세싱 시장 개요
세계의 대규모 및 소규모 바이오프로세싱 시장 규모는 2025년에 933억 2,000만 달러로 추정되며, 2033년에 2,287억 3,000만 달러에 달할 것으로 예측됩니다.
2026년부터 2033년까지 CAGR 11.39%로 성장할 것으로 예상됩니다. 이 같은 성장의 주요 원인은 단클론항체, 백신, 세포 및 유전자 치료제를 포함한 생물학적 제제에 대한 전 세계 수요 증가에 기인합니다.
바이오 제약 기업들은 개발 기간 단축과 생산 비용 절감에 기여하는 일회용 기술 및 모듈형 바이오프로세싱 시스템과 같은 유연한 제조 솔루션에 많은 투자를 하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 대규모 및 소규모 바이오프로세싱 시장의 변수, 동향과 범위
- 시장 계통 전망
- 상부 시장 전망
- 관련·부수 시장 전망
- 시장 역학
- 대규모 및 소규모 바이오프로세싱 시장 분석 툴
- 산업 분석 : Porter's Five Forces
- PESTEL 분석
제4장 대규모 및 소규모 바이오프로세싱 시장 : 규모별, 추정·동향 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장의 규모 변동 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(규모별, 2021-2033년)
- 산업 규모(50,000리터 이상)
- 소규모(50,000리터 이하)
제5장 대규모 및 소규모 바이오프로세싱 시장 : 제품별, 추정·동향 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장의 제품 변동 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(제품별, 2021-2033년)
- 바이오 원자로/발효조
- 세포배양 제품
- 바이오 원자로 부속품
- 여과 어셈블리
- 백과 용기
- 기타
제6장 대규모 및 소규모 바이오프로세싱 시장 : 용도별, 추정·동향 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장의 용도 변동 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(용도별, 2021-2033년)
- 바이오의약품
- 특수 산업용 화학제품
- 환경 보조제
제7장 대규모 및 소규모 바이오프로세싱 시장 : 사용 유형별, 추정·동향 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장의 사용 유형 변동 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(사용 유형별, 2021-2033년)
- 다회용
- 일회용
제8장 대규모 및 소규모 바이오프로세싱 시장 : 모드별, 추정·동향 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장의 모드 변동 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(모드별, 2021-2033년)
- 자사내
- 외부 위탁
제9장 대규모 및 소규모 바이오프로세싱 시장 : 워크플로우별, 추정·동향 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장의 워크플로우 변동 분석
- 세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(워크플로우별, 2021-2033년)
- 다운스트림 프로세싱
- 발효
- 업스트림 프로세싱
제10장 대규모 및 소규모 바이오프로세싱 시장 : 지역별, 추정·동향 분석
- 지역별 시장 점유율 분석(2025년과 2033년)
- 지역별 시장 대시보드
- 시장 규모와 예측 동향 분석, 2021-2033년
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
- 아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
- 라틴아메리카
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
제11장 경쟁 구도
- 기업/경쟁 분류
- 전략 매핑
- 2025년의 기업 시장 상황 분석
- 기업 개요/리스트
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Danaher(Cytiva)
- Corning, Inc.
- Sartorius AG
- CESCO BIOENGINEERING CO., LTD
- Bio-Process Group
- BPC Instruments AB
- Eppendorf AG
- Getinge AB
- Lonza
- PBS BIoTech, Inc
- Bio-Synthesis, Inc.
- Meissner Filtration Products, Inc.
- Entegris
- KUHNER AG
- Saint-Gobain
- ExcellGene SA
- Repligen Corporation
- Avantor, Inc
- CerCell A/S
- Univercells Technologies
- Distek, Inc.
- F. Hoffmann-La Roche Ltd
Large And Small-scale Bioprocessing Market Summary
The global large and small-scale bioprocessing market size was estimated at USD 93.32 billion in 2025 and is expected to reach USD 228.73 billion by 2033, growing at a CAGR of 11.39% from 2026 to 2033. This substantial growth is primarily driven by the increasing global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies.
Biopharmaceutical companies invest significantly in flexible manufacturing solutions, such as single-use technologies and modular bioprocessing systems, which help accelerate development timelines and reduce production costs.
Global Large And Small-scale Bioprocessing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global large- and small-scale bioprocessing market report on the basis of scale, workflow, product, application, use type, mode, and region.
- Scale Outlook (Revenue, USD Million, 2021 - 2033)
- Industrial Scale (Over 50,000 Liter)
- Small Scale (Less Than 50,000 Liter)
- Workflow Outlook (Revenue, USD Million, 2021 - 2033)
- Downstream Processing
- Fermentation
- Upstream Processing
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Bioreactors/Fermenters
- Cell Culture Products
- Filtration Assemblies
- Bioreactors Accessories
- Bags & Containers
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Biopharmaceuticals
- Specialty Industrial Chemicals
- Environmental Aids
- Use Type Outlook (Revenue, USD Million, 2021 - 2033)
- Multi-Use
- Single-Use
- Mode Outlook (Revenue, USD Million, 2021 - 2033)
- In-house
- Outsourced
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. SCALE
- 1.2.2. WORKFLOW
- 1.2.3. PRODUCT
- 1.2.4. APPLICATION
- 1.2.5. MODE
- 1.2.6. USE TYPE
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. Large- and Small-Scale Bioprocessing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing implementation of single-use technology (SUT) for bioproduction
- 3.2.1.2. Rising demand for biologics
- 3.2.2. Market restraint analysis
- 3.2.2.1. High initial setup and operational costs for large-scale bioprocessing
- 3.2.2.2. Complexity and regulatory hurdles
- 3.2.1. Market driver analysis
- 3.3. Large- and small-scale bioprocessing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
Chapter 4. Large- and Small-Scale Bioprocessing Market: Scale Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Large- and Small-Scale Bioprocessing Market Service Scale Movement Analysis
- 4.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Scale, 2021 to 2033 (USD Million)
- 4.4. Industrial Scale (Over 50,000 Liter)
- 4.4.1. Industrial Scale (Over 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5. Small Scale (Less Than 50,000 Liter)
- 4.5.1. Small Scale (Less Than 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Large- and Small-Scale Bioprocessing Market: Product Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Large- and Small-Scale Bioprocessing Market Product Movement Analysis
- 5.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 5.4. Bioreactors/Fermenters
- 5.4.1. Bioreactors/Fermenters market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5. Cell Culture Products
- 5.5.1. Cell Culture Products market estimates and forecasts 2021 to 2033 (USD Million)
- 5.6. Bioreactors Accessories
- 5.6.1. Bioreactors Accessories market estimates and forecasts 2021 to 2033 (USD Million)
- 5.7. Filtration Assemblies
- 5.7.1. Filtration Assemblies market estimates and forecasts 2021 to 2033 (USD Million)
- 5.8. Bags & Containers
- 5.8.1. Bags & Containers market estimates and forecasts 2021 to 2033 (USD Million)
- 5.9. Others
- 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Large- and Small-Scale Bioprocessing Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Large- and Small-Scale Bioprocessing Market Application Movement Analysis
- 6.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Biopharmaceuticals
- 6.4.1. Biopharmaceuticals market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5. Specialty Industrial Chemicals
- 6.5.1. Specialty Industrial Chemicals market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6. Environmental Aids
- 6.6.1. Environmental Aids market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Large- and Small-Scale Bioprocessing Market: Use Type Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Large- and Small-Scale Bioprocessing Market Use Type Movement Analysis
- 7.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Use Type, 2021 to 2033 (USD Million)
- 7.4. Multi-Use
- 7.4.1. . Multi-Use market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5. . Single-Use
- 7.5.1. Single-Use market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Large- and Small-Scale Bioprocessing Market: Mode Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Global Large- and Small-Scale Bioprocessing Market Mode Movement Analysis
- 8.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
- 8.4. . In-House
- 8.4.1. In-House market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5. . Outsourced
- 8.5.1. Outsourced market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Large- and Small-Scale Bioprocessing Market: Workflow Estimates & Trend Analysis
- 9.1. Segment Dashboard
- 9.2. Global Large- and Small-Scale Bioprocessing Market Workflow Movement Analysis
- 9.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
- 9.4. Downstream Processing
- 9.4.1. Downstream Processing market estimates and forecasts 2021 to 2033 (USD Million)
- 9.5. Fermentation
- 9.5.1. Fermentation market estimates and forecasts 2021 to 2033 (USD Million)
- 9.6. Upstream Processing
- 9.6.1. Upstream Processing market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Large- and Small-Scale Bioprocessing Market: Regional Estimates & Trend Analysis
- 10.1. Regional Market Share Analysis, 2025 & 2033
- 10.2. Regional Market Dashboard
- 10.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 10.4. North America
- 10.4.1. U.S.
- 10.4.1.1. Key country dynamics
- 10.4.1.2. Regulatory Framework
- 10.4.1.3. Competitive scenario
- 10.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 10.4.2. Canada
- 10.4.2.1. Key country dynamics
- 10.4.2.2. Regulatory Framework
- 10.4.2.3. Competitive scenario
- 10.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 10.4.3. Mexico
- 10.4.3.1. Key country dynamics
- 10.4.3.2. Competitive scenario
- 10.4.3.3. Regulatory Framework
- 10.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
- 10.4.1. U.S.
- 10.5. Europe
- 10.5.1. UK
- 10.5.1.1. Key country dynamics
- 10.5.1.2. Competitive scenario
- 10.5.1.3. Regulatory Framework
- 10.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.2. Germany
- 10.5.2.1. Key country dynamics
- 10.5.2.2. Competitive scenario
- 10.5.2.3. Regulatory Framework
- 10.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.3. France
- 10.5.3.1. Key country dynamics
- 10.5.3.2. Competitive scenario
- 10.5.3.3. France market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.4. Italy
- 10.5.4.1. Key country dynamics
- 10.5.4.2. Competitive scenario
- 10.5.4.3. Regulatory Framework
- 10.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.5. Spain
- 10.5.5.1. Key country dynamics
- 10.5.5.2. Competitive scenario
- 10.5.5.3. Regulatory Framework
- 10.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.6. Norway
- 10.5.6.1. Key country dynamics
- 10.5.6.2. Competitive scenario
- 10.5.6.3. Regulatory Framework
- 10.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.7. Sweden
- 10.5.7.1. Key country dynamics
- 10.5.7.2. Competitive scenario
- 10.5.7.3. Regulatory Framework
- 10.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.8. Denmark
- 10.5.8.1. Key country dynamics
- 10.5.8.2. Competitive scenario
- 10.5.8.3. Regulatory Framework
- 10.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 10.5.1. UK
- 10.6. Asia Pacific
- 10.6.1. Japan
- 10.6.1.1. Key country dynamics
- 10.6.1.2. Competitive scenario
- 10.6.1.3. Regulatory Framework
- 10.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 10.6.2. China
- 10.6.2.1. Key country dynamics
- 10.6.2.2. Competitive scenario
- 10.6.2.3. Regulatory Framework
- 10.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 10.6.3. India
- 10.6.3.1. Key country dynamics
- 10.6.3.2. Competitive scenario
- 10.6.3.3. Regulatory Framework
- 10.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 10.6.4. Australia
- 10.6.4.1. Key country dynamics
- 10.6.4.2. Competitive scenario
- 10.6.4.3. Regulatory Framework
- 10.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 10.6.5. South Korea
- 10.6.5.1. Key country dynamics
- 10.6.5.2. Competitive scenario
- 10.6.5.3. Regulatory Framework
- 10.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 10.6.6. Thailand
- 10.6.6.1. Key country dynamics
- 10.6.6.2. Competitive scenario
- 10.6.6.3. Regulatory Framework
- 10.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
- 10.6.1. Japan
- 10.7. Latin America
- 10.7.1. Brazil
- 10.7.1.1. Key country dynamics
- 10.7.1.2. Competitive scenario
- 10.7.1.3. Regulatory Framework
- 10.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 10.7.2. Argentina
- 10.7.2.1. Key country dynamics
- 10.7.2.2. Competitive scenario
- 10.7.2.3. Regulatory Framework
- 10.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 10.7.1. Brazil
- 10.8. Middle East and Africa
- 10.8.1. South Africa
- 10.8.1.1. Key country dynamics
- 10.8.1.2. Competitive scenario
- 10.8.1.3. Regulatory Framework
- 10.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 10.8.2. Saudi Arabia
- 10.8.2.1. Key country dynamics
- 10.8.2.2. Competitive scenario
- 10.8.2.3. Regulatory Framework
- 10.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 10.8.3. UAE
- 10.8.3.1. Key country dynamics
- 10.8.3.2. Competitive scenario
- 10.8.3.3. Regulatory Framework
- 10.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 10.8.4. Kuwait
- 10.8.4.1. Key country dynamics
- 10.8.4.2. Competitive scenario
- 10.8.4.3. Regulatory Framework
- 10.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 10.8.1. South Africa
Chapter 11. Competitive Landscape
- 11.1. Company/Competition Categorization
- 11.2. Strategy Mapping
- 11.3. Company Market Position Analysis, 2025
- 11.4. Company Profiles/Listing
- 11.4.1. Merck KGaA
- 11.4.1.1. Company overview
- 11.4.1.2. Financial performance
- 11.4.1.3. Product benchmarking
- 11.4.1.4. Strategic initiatives
- 11.4.2. Thermo Fisher Scientific, Inc.
- 11.4.2.1. Company overview
- 11.4.2.2. Financial performance
- 11.4.2.3. Product benchmarking
- 11.4.2.4. Strategic initiatives
- 11.4.3. Danaher (Cytiva)
- 11.4.3.1. Company overview
- 11.4.3.2. Financial performance
- 11.4.3.3. Product benchmarking
- 11.4.3.4. Strategic initiatives
- 11.4.4. Corning, Inc.
- 11.4.4.1. Company overview
- 11.4.4.2. Financial performance
- 11.4.4.3. Product benchmarking
- 11.4.4.4. Strategic initiatives
- 11.4.5. Sartorius AG
- 11.4.5.1. Company overview
- 11.4.5.2. Financial performance
- 11.4.5.3. Product benchmarking
- 11.4.5.4. Strategic initiatives
- 11.4.6. CESCO BIOENGINEERING CO., LTD
- 11.4.6.1. Company overview
- 11.4.6.2. Financial performance
- 11.4.6.3. Product benchmarking
- 11.4.6.4. Strategic initiatives
- 11.4.7. Bio-Process Group
- 11.4.7.1. Company overview
- 11.4.7.2. Financial performance
- 11.4.7.3. Product benchmarking
- 11.4.7.4. Strategic initiatives
- 11.4.8. BPC Instruments AB
- 11.4.8.1. Company overview
- 11.4.8.2. Financial performance
- 11.4.8.3. Product benchmarking
- 11.4.8.4. Strategic initiatives
- 11.4.9. Eppendorf AG
- 11.4.9.1. Company overview
- 11.4.9.2. Financial performance
- 11.4.9.3. Product benchmarking
- 11.4.9.4. Strategic initiatives
- 11.4.10. Getinge AB
- 11.4.10.1. Company overview
- 11.4.10.2. Financial performance
- 11.4.10.3. Product benchmarking
- 11.4.10.4. Strategic initiatives
- 11.4.11. Lonza
- 11.4.11.1. Company overview
- 11.4.11.2. Financial performance
- 11.4.11.3. Product benchmarking
- 11.4.11.4. Strategic initiatives
- 11.4.12. PBS Biotech, Inc
- 11.4.12.1. Company overview
- 11.4.12.2. Financial performance
- 11.4.12.3. Product benchmarking
- 11.4.12.4. Strategic initiatives
- 11.4.13. Bio-Synthesis, Inc.
- 11.4.13.1. Company overview
- 11.4.13.2. Financial performance
- 11.4.13.3. Product benchmarking
- 11.4.13.4. Strategic initiatives
- 11.4.14. Meissner Filtration Products, Inc.
- 11.4.14.1. Company overview
- 11.4.14.2. Financial performance
- 11.4.14.3. Product benchmarking
- 11.4.14.4. Strategic initiatives
- 11.4.15. Entegris
- 11.4.15.1. Company overview
- 11.4.15.2. Financial performance
- 11.4.15.3. Product benchmarking
- 11.4.15.4. Strategic initiatives
- 11.4.16. KUHNER AG
- 11.4.16.1. Company overview
- 11.4.16.2. Financial performance
- 11.4.16.3. Product benchmarking
- 11.4.16.4. Strategic initiatives
- 11.4.17. Saint-Gobain
- 11.4.17.1. Company overview
- 11.4.17.2. Financial performance
- 11.4.17.3. Product benchmarking
- 11.4.17.4. Strategic initiatives
- 11.4.18. ExcellGene SA
- 11.4.18.1. Company overview
- 11.4.18.2. Financial performance
- 11.4.18.3. Product benchmarking
- 11.4.18.4. Strategic initiatives
- 11.4.19. Repligen Corporation
- 11.4.19.1. Company overview
- 11.4.19.2. Financial performance
- 11.4.19.3. Product benchmarking
- 11.4.19.4. Strategic initiatives
- 11.4.20. Avantor, Inc
- 11.4.20.1. Company overview
- 11.4.20.2. Financial performance
- 11.4.20.3. Product benchmarking
- 11.4.20.4. Strategic initiatives
- 11.4.21. CerCell A/S
- 11.4.21.1. Company overview
- 11.4.21.2. Financial performance
- 11.4.21.3. Product benchmarking
- 11.4.21.4. Strategic initiatives
- 11.4.22. Univercells Technologies
- 11.4.22.1. Company overview
- 11.4.22.2. Financial performance
- 11.4.22.3. Product benchmarking
- 11.4.22.4. Strategic initiatives
- 11.4.23. Distek, Inc.
- 11.4.23.1. Company overview
- 11.4.23.2. Financial performance
- 11.4.23.3. Product benchmarking
- 11.4.23.4. Strategic initiatives
- 11.4.24. F. Hoffmann-La Roche Ltd
- 11.4.24.1. Company overview
- 11.4.24.2. Financial performance
- 11.4.24.3. Product benchmarking
- 11.4.24.4. Strategic initiatives
- 11.4.1. Merck KGaA
샘플 요청 목록